377 related articles for article (PubMed ID: 23085062)
1. Urinary NGAL and KIM-1: biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery.
Abassi Z; Shalabi A; Sohotnik R; Nativ O; Awad H; Bishara B; Frajewicki V; Sukhotnik I; Abbasi A; Nativ O
J Urol; 2013 Apr; 189(4):1559-66. PubMed ID: 23085062
[TBL] [Abstract][Full Text] [Related]
2. Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.
Lahoud Y; Hussein O; Shalabi A; Nativ O; Awad H; Khamaisi M; Matar I; Nativ O; Abassi Z
World J Urol; 2015 Dec; 33(12):2053-62. PubMed ID: 25981401
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB
Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
Morrissey JJ; London AN; Lambert MC; Kharasch ED
Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
[TBL] [Abstract][Full Text] [Related]
6. Implication of combined urinary biomarkers in early diagnosis of acute kidney injury following percutaneous coronary intervention.
Luo Q; Zhou F; Dong H; Wu L; Chai L; Lan K; Wu M
Clin Nephrol; 2013 Feb; 79(2):85-92. PubMed ID: 23110770
[TBL] [Abstract][Full Text] [Related]
7. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
8. Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6 months of age.
Hazle MA; Gajarski RJ; Aiyagari R; Yu S; Abraham A; Donohue J; Blatt NB
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):861-867.e1. PubMed ID: 23317940
[TBL] [Abstract][Full Text] [Related]
9. Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication.
Gil HW; Yang JO; Lee EY; Hong SY
Clin Toxicol (Phila); 2009 Nov; 47(9):870-5. PubMed ID: 19827907
[TBL] [Abstract][Full Text] [Related]
10. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
Wang L; Pu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
[TBL] [Abstract][Full Text] [Related]
11. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
12. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
[TBL] [Abstract][Full Text] [Related]
13. Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure.
Verbrugge FH; Dupont M; Shao Z; Shrestha K; Singh D; Finucan M; Mullens W; Tang WH
J Card Fail; 2013 Sep; 19(9):621-8. PubMed ID: 24054338
[TBL] [Abstract][Full Text] [Related]
14. Pre-transplant Evaluation of Donor Urinary Biomarkers can Predict Reduced Graft Function After Deceased Donor Kidney Transplantation.
Koo TY; Jeong JC; Lee Y; Ko KP; Lee KB; Lee S; Park SJ; Park JB; Han M; Lim HJ; Ahn C; Yang J
Medicine (Baltimore); 2016 Mar; 95(11):e3076. PubMed ID: 26986138
[TBL] [Abstract][Full Text] [Related]
15. Urinary biomarkers after donor nephrectomy.
Hoogendijk-van den Akker JM; Warlé MC; van Zuilen AD; Kloke HJ; Wever KE; d'Ancona FC; Ӧzdemir DM; Wetzels JF; Hoitsma AJ
Transpl Int; 2015 May; 28(5):544-52. PubMed ID: 25581388
[TBL] [Abstract][Full Text] [Related]
16. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
[TBL] [Abstract][Full Text] [Related]
17. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.
Torregrosa I; Montoliu C; Urios A; Andrés-Costa MJ; Giménez-Garzó C; Juan I; Puchades MJ; Blasco ML; Carratalá A; Sanjuán R; Miguel A
Heart Vessels; 2015 Nov; 30(6):703-11. PubMed ID: 24989970
[TBL] [Abstract][Full Text] [Related]
18. [Association between urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery].
Wan X; Cao CC; Chen Y; Xiao YL; Wu WF; Chen X; Mu XW
Zhonghua Yi Xue Za Zhi; 2008 May; 88(19):1318-22. PubMed ID: 18956700
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of Urinary Calprotectin after Renal Ischaemia.
Ebbing J; Seibert FS; Pagonas N; Bauer F; Miller K; Kempkensteffen C; Günzel K; Bachmann A; Seifert HH; Rentsch CA; Ardelt P; Wetterauer C; Amico P; Babel N; Westhoff TH
PLoS One; 2016; 11(1):e0146395. PubMed ID: 26745147
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
Bhavsar NA; Köttgen A; Coresh J; Astor BC
Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
